Companies · SGRY
Surgery Partners
AI-generated · informational only · not investment advice · verify before relying.
Latest analysis
Updated Oct 26, 2026
HealthSpan Partners to acquire Surgery Partners for $23.50/share in all-cash deal at ~$5.7B enterprise value, expected to close Q1 2027.
Surgery Partners has entered into a definitive merger agreement with HealthSpan Partners, an affiliate of Bon Secours Mercy Health, in an all-cash transaction at $23.50 per share representing approximately $5.7 billion in enterprise value — the company's most consequential strategic event in its history. Bain Capital, Surgery Partners' largest shareholder at approximately 39% of outstanding shares, will roll over its equity into the acquiring entity and remain a significant partner post-closing. The transaction, approved unanimously by a Special Committee of independent directors, is expected to close in Q1 2027, subject to stockholder and regulatory approvals; upon closing, Surgery Partners will be delisted from Nasdaq and operate as a privately held company.
Tone: bullishRevenue
$3.3B
SGRY 10-K · FY 2025
Employees
16,000
Revenue FY2024
$3.1B
Founded
2004
Profile
SGRY 10-K Item 1 · Mar 2, 2026Surgery Partners owns and operates a national network of ambulatory surgery centers, short-stay surgical hospitals, and ancillary services across 30 states, serving patients and physicians with high-quality, cost-effective outpatient surgical care. The company operates 176 surgical facilities as of December 31, 2025, partnering with physicians and health systems in majority- and minority-ownership structures. Its integrated outpatient delivery model focuses on non-emergency, scheduled surgical procedures across multiple specialties.
Read filing description ↓ Collapse description ↑
We are a leading healthcare services company with an integrated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. We are one of the largest and fastest growing surgical services businesses in the United States, with more than 200 locations in 30 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices, among others. Patient services provided in our ASCs and surgical hospitals generated approximately $3.2 billion in revenue during 2025. Our surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology and general surgery. We own and operate our surgical facilities through partnerships or limited liability companies with physicians, physician groups and health care systems. We provide each of our surgical facilities with a full range of financial, marketing and operating services. Our growth strategy employs a multifaceted approach including physician engagement, organic growth through service line expansion and physician recruitment, disciplined acquisitions, and partnerships with payors and health systems. We believe favorable industry trends such as an aging population, advancements in medical technology and payor and government encouragement to move high acuity procedures from acute care to lower cost sites of care will further drive growth.
Primary products
- Ambulatory surgery centers (ASCs)
- Short-stay surgical hospitals
- Multi-specialty physician practices
- Anesthesia services
- Urgent care facilities
- Management and administrative services
Business segments
End markets
Geographies
Named competitors
“We are one of the largest and fastest growing surgical services businesses in the United States, with more than 200 locations in 30 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices, among others.” Competitive position, as stated in the filing
Revenue commentary · FY 2025
Total revenues for 2025 increased 6.2% to $3.3 billion from $3.1 billion in 2024, driven by same-facility revenue growth and the net impact from acquisitions and divestitures completed during the year.
The rest of SGRY is for subscribers
Analysis, signals, diligence answers, M&A activity and every quote, each citing the filing it came from.